Targeting Activated Akt with GDC-0068, a Novel Selective Akt Inhibitor That Is Efficacious in Multiple Tumor Models-Reference-Cited by-同舟云学术

Targeting Activated Akt with GDC-0068, a Novel Selective Akt Inhibitor That Is Efficacious in Multiple Tumor Models

Published:2013-01-03 Issue:7 Volume:19 Page:1760-1772
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Lin Jie,Sampath Deepak,Nannini Michelle A.,Lee Brian B.,Degtyarev Michael,Oeh Jason,Savage Heidi,Guan Zhengyu,Hong Rebecca,Kassees Robert,Lee Leslie B.,Risom Tyler,Gross Stefan,Liederer Bianca M.,Koeppen Hartmut,Skelton Nicholas J.,Wallin Jeffrey J.,Belvin Marcia,Punnoose Elizabeth,Friedman Lori S.,Lin Kui

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications;Molecules;2024-09-04

2. Efficacy and safety analysis of AKT inhibitor in triple-negative breast cancer: A meta-analysis and systematic review;Medicine;2024-08-30

3. Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors;Frontiers in Pharmacology;2024-08-29

4. Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis;Cardiovascular Research;2024-08-28

5. Vascular endothelial cell morphology and alignment regulate VEGF‐induced endothelial nitric oxide synthase activation;Cytoskeleton;2024-05-22